Childhood Cancer

You are here

Home » Grants » All grants tagged with "Lymphoma"

All grants tagged with "Lymphoma"

Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias
Andre Nussenzweig, Ph.D.
National Cancer Institute
Reach Grants, Awarded 2014
The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia
Wei Tong, PhD
Children’s Hospital of Philadelphia
Innovation Grants, Awarded 2014
Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia
Linda Resar, M.D.
The Johns Hopkins University School of Medicine
Innovation Grants, Awarded 2014
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer
Stephen Gottschalk, M.D.
Baylor College of Medicine
Innovation Grants, Awarded 2014
Optimizing Engager T-cells for CD19+ Malignancies
Mireya Paulina Velasquez, MD
Baylor College of Medicine
Young Investigator Grants, Awarded 2014
Investigation of Mechanisms Contributing to EBV-induced Lymphoproliferation in ITK-Deficiency
Sarah Thornton
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2013
Epstein-Barr Virus Genetic Variation in Children with Burkitt Lymphoma
Richard Otieno
SUNY Upstate Medical University
POST Program Grants, Awarded 2013
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies
Stephen Gottschalk, MD
Baylor College of Medicine
Innovation Grants, Awarded 2013
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1
Loren Walensky, MD, PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2013
Epigenetic Regulation of T cell Activation and Immunotherapy
Brian Ladle, MD, PhD
The Johns Hopkins University School of Medicine
Young Investigator Grants, Awarded 2013

Pages

All childhood cancer types

Featured Hero

Seth Walsh

Seth is spunky and can be friends with anyone. After being diagnosed with ALL, Seth endured countless trips out-of-state, four relapses, two CAR T-cell therapies, two bone marrow transplants, and one clinical trial. Today, Seth has reached remission!
Read more »